| 1/13/2021 |
4 microbiome companies turning gut bacteria into tomorrow's drugs |
Business Insider |
... microbiome drug candidates. For more stories like this, sign up here for Business Insider's daily healthcare newsletter. 2021 could be the year of the microbiome.That's at least one top healthcare venture capital ist's prediction. Venrock partner Racquel Bracken anticipates more success will come for drugs tapping the mix of living microorganisms that live in and on our bodies.In December, Business Insider asked 29 ... |
| 12/3/2020 |
Jumpstart Capital Growth Fund I Exits Stake in Casetabs as Team Continues Focus on Digital Health with New Brand and Fund – Caduceus Capital Partners |
PRWeb |
... with a gross internal rate of return of more than 100% on the exit of its equity position. The rapid growth and return are a testament to the supportive depth and breadth of Nashville's healthcare venture capital community. "Dave Vreeland and I were introduced in Nashville by a mutual friend in the industry a couple of years ago. Our company needed both capital and guidance and with Jumpstart Capital's decision ... |
| 11/22/2020 |
aMoon and Roche to cooperate on digital health - Globes |
globes.co.il |
The Israeli venture capital fund and the pharmaceutical giant will invest in nine early stage startups.Israeli healthcare venture capital fund aMoon and pharmaceutical giant Roche have launched a joint program for investment in early stage digital health companies. The project is called the Starfinder Digital Innovation Lab. The companies will mark out each year, for the next three years, three subsectors in the field of digital health and will ... |
| 11/18/2020 |
Lumira Ventures Appoints Special Advisors and Venture Partner |
itbusinessnet.com |
Veteran Pharmaceutical Industry Executives Will Advise Portfolio Companies and Investment Team TORONTO, ON Lumira Ventures, a leading North American healthcare venture capital firm, today announced the appointment of Theodore Witek, Jr., DrPH, MBA and Daniel Billen, PhD to the role of Special Advisor, and Sena Biswas, PhD, MBA as Venture Partner.“We are excited to welcome Ted, Daniel and Sena to the Lumira Ventures team,” commented Peter van der ... |
| 10/30/2020 |
5th LifeSciences BC Investor Summit Attracts International Interest | Business & Finance | manchestertimes.com |
Business Wire |
VANCOUVER, British Columbia--(BUSINESS WIRE)--Oct 30, 2020--LifeSciences BC , a non-profit, industry association which supports the life sciences sector of British Columbia, and Lumira Ventures , a leading North American healthcare venture capital firm, will host the 5th Annual LifeSciences BC’s Investor Summit in Vancouver, B.C., virtually on November 2 nd and 3 rd, 2020.With keynotes given by Mr. Daniel Hétu, Managing Director of Lumira Ventures ... |
| 10/30/2020 |
5th LifeSciences BC Investor Summit Attracts International Interest |
tmcnet.com |
... October 30, 2020] 5th LifeSciences BC Investor Summit Attracts International InterestLifeSciences BC , a non-profit, industry association which supports the life sciences sector of British Columbia, and Lumira Ventures , a leading North American healthcare venture capital firm, will host the 5th Annual LifeSciences BC's Investor Summit in Vancouver, B.C., virtually on November 2 nd and 3 rd , 2020.With keynotes given by Mr. Daniel Hétu, Managing Director of ... |
| 10/29/2020 |
5th LifeSciences BC Investor Summit (Virtual) Attracts International Interest |
pharmavoice.com |
LifeSciences BC , a non-profit, industry association which supports the life sciences sector of British Columbia, and Lumira Ventures , a leading North American healthcare venture capital firm, will host the 5th Annual LifeSciences BC’s Investor Summit in Vancouver, B.C., virtually on November 2nd and 3rd, 2020 .With keynotes given by Mr. Daniel Hétu, Managing Director of Lumira Ventures and Mr. Peter Greenleaf, CEO of Aurinia Pharmaceuticals, the event ... |
| 10/22/2020 |
Enviral Tech Closes $1.5M Funding Round to Expand Service for Early Detection of COVID-19 Outbreaks |
PR Newswire |
... announced the close of $1.5M in seed funding, which enables the company to meet growing demands from the long-term care facilities, schools, and business marketplaces. The round was led by Oregon technology and healthcare venture capital fund, Rogue Venture Partners, with additional investments from Cascade Seed Fund and private investors.Caroline Lewis , Managing Partner of Rogue Venture Partners, said, "We invested in Enviral Tech because of the high caliber ... |
| 10/22/2020 |
Enviral Tech Closes $1.5M Funding Round to Expand Service for Early Detection of COVID-19 Outbreaks |
vcaonline.com |
... announced the close of $1.5M in seed funding, which enables the company to meet growing demands from the long-term care facilities, schools, and business marketplaces. The round was led by Oregon technology and healthcare venture capital fund, Rogue Venture Partners, with additional investments from Cascade Seed Fund and private investors. Caroline Lewis, Managing Partner of Rogue Venture Partners, said, "We invested in Enviral Tech because of the high caliber ... |
| 10/22/2020 |
Enviral Tech Closes $1.5M Funding Round to Expand Service for Early Detection of COVID-19 Outbreaks |
BioSpace |
... announced the close of $1.5M in seed funding, which enables the company to meet growing demands from the long-term care facilities, schools, and business marketplaces. The round was led by Oregon technology and healthcare venture capital fund, Rogue Venture Partners, with additional investments from Cascade Seed Fund and private investors.Caroline Lewis , Managing Partner of Rogue Venture Partners, said, "We invested in Enviral Tech because of the high caliber ... |
| 10/13/2020 |
Gore Range Capital Bolsters Advisory Board for Skin Health Investments |
Business Wire |
DALLAS--(BUSINESS WIRE)--Oct 13, 2020--Gore Range Capital (“Gore Range”), a healthcare venture capital firm, today announced the expansion of its Industry Advisory Board (“IAB”), adding substantial skin health expertise for the launch of Gore Range Capital Fund II (“Fund II”).Joining the IAB for Fund II are Dr. April W. Armstrong, Dr. Neal Bhatia, Dr. Joel L. Cohen, Dr. Seemal R. Desai, Dr. Aaron S. Farberg, Dr. Gary ... |
| 10/13/2020 |
Gore Range Capital Bolsters Advisory Board for Skin Health Investments |
tmcnet.com |
Gore Range Capital Bolsters Advisory Board for Skin Health Investments [October 13, 2020] Gore Range Capital Bolsters Advisory Board for Skin Health InvestmentsGore Range Capital ("Gore Range"), a healthcare venture capital firm, today announced the expansion of its Industry Advisory Board ("IAB"), adding substantial skin health expertise for the launch of Gore Range Capital Fund II ("Fund II").Joining the IAB for Fund II are Dr. April W. Armstrong ... |
| 9/23/2020 |
Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies |
Globe Newswire |
... life, and drive efficiency in healthcare delivery -- In 2020 to date, Longitude portfolio companies announced 4 IPOs and 3 M&A transactions -MENLO PARK, Calif. and GREENWICH, Conn. and BOSTON, Longitude Capital, a leading healthcare venture capital firm, today announced the closing of Longitude Venture Partners IV, L.P. (“LVP4”), with $585 million in capital commitments. LVP4, the largest fund that Longitude Capital has raised to date, will build on the ... |
| 9/23/2020 |
Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies |
Globe Newswire |
... drive efficiency in healthcare delivery - - In 2020 to date, Longitude portfolio companies announced 4 IPOs and 3 M&A transactions - MENLO PARK, Calif. and GREENWICH, Conn. and BOSTON, Sept. 23, Longitude Capital, a leading healthcare venture capital firm, today announced the closing of Longitude Venture Partners IV, L.P. (“LVP4”), with $585 million in capital commitments. LVP4, the largest fund that Longitude Capital has raised to date, will build on the ... |
| 9/23/2020 |
Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies |
BioSpace |
... healthcare delivery -- In 2020 to date, Longitude portfolio companies announced 4 IPOs and 3 M&A transactions -MENLO PARK, Calif. and GREENWICH, Conn. and BOSTON, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Longitude Capital, a leading healthcare venture capital firm, today announced the closing of Longitude Venture Partners IV, L.P. (“LVP4”), with $585 million in capital commitments. LVP4, the largest fund that Longitude Capital has raised to date, will build on the ... |
| 9/23/2020 |
Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies |
firstwordpharma.com |
... healthcare delivery -- In 2020 to date, Longitude portfolio companies announced 4 IPOs and 3 M&A transactions -MENLO PARK, Calif. and GREENWICH, Conn. and BOSTON, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Longitude Capital, a leading healthcare venture capital firm, today announced the closing of Longitude Venture Partners IV, L.P. ("LVP4"), with $585 million in capital commitments. LVP4, the largest fund that Longitude Capital has raised to date, will build on the ... |
| 9/23/2020 |
CERTNEXUS ANNOUNCES THE RELEASE OF ITS DATA ETHICS PROFESSIONAL CERTIFICATION ON COURSERA |
einnews.com |
... efficiency in healthcare delivery - - In 2020 to date, Longitude portfolio companies announced 4 IPOs and 3 M&A transactions - MENLO PARK, Calif. and GREENWICH, Conn. and BOSTON, September 23, 2020-- Longitude Capital, a leading healthcare venture capital firm, today announced the closing of Longitude Venture Partners IV, L.P. (LVP4), with $585 million in capital commitments. LVP4, the largest fund that Longitude Capital has raised to date, will build on the ... |
| 9/23/2020 |
Monte Rosa Secures $96 Million to Advance Small-Molecule Drug Discovery Platform |
BioSpace |
... healthcare delivery -- In 2020 to date, Longitude portfolio companies announced 4 IPOs and 3 M&A transactions -MENLO PARK, Calif. and GREENWICH, Conn. and BOSTON, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Longitude Capital, a leading healthcare venture capital firm, today announced the closing of Longitude Venture Partners IV, L.P. (“LVP4”), with $585 million in capital commitments. LVP4, the largest fund that Longitude Capital has raised to date, will build on the ... |
| 9/16/2020 |
Graphite Bio Launches with $45 Million Series A Financing |
Business Wire |
... academic pioneers in the fields of gene editing and gene therapy, and is backed by Versant Ventures and Samsara BioCapital. For more information, please visit www.graphitebio.com . About Versant Ventures Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $3.2 billion under management and ... |
| 9/9/2020 |
Uber Health's top exec departs |
Becker's Hospital Review |
... 1,000 healthcare organizations to build out its healthcare transportation business. Uber Health has yet to name a replacement for Mr. Trigub, according to STAT. Mr. Trigub’s startup will be incubated by Redesign Health, a healthcare venture capital firm that has backed several health-related companies like hearing aid developer Lively and men's direct-to-consumer startup Vault Health. Read the full report here. More articles on leadership and management ... |